How can we really improve screening methods for AD prevention trials?

John C.S. Breitner

doi:10.1016/j.trci.2015.12.004

How can we really improve screening methods for AD prevention trials?

John C.S. Breitner

School of Medicine

Research output: Contribution to journal › Short survey › peer-review

Original language	English (US)
Pages (from-to)	45-47
Number of pages	3
Journal	Alzheimer's and Dementia: Translational Research and Clinical Interventions
Volume	2
Issue number	1
DOIs	https://doi.org/10.1016/j.trci.2015.12.004
State	Published - Jan 1 2016

ASJC Scopus subject areas

Clinical Neurology
Psychiatry and Mental health

Access to Document

10.1016/j.trci.2015.12.004

Cite this

@article{358de25be7d44c64b0dc7a181452efa9,

title = "How can we really improve screening methods for AD prevention trials?",

author = "Breitner, {John C.S.}",

year = "2016",

month = jan,

day = "1",

doi = "10.1016/j.trci.2015.12.004",

language = "English (US)",

volume = "2",

pages = "45--47",

journal = "Alzheimer's and Dementia: Translational Research and Clinical Interventions",

issn = "2352-8737",